MATCP: Mechanisms of Affective Touch in Chronic Pain

Sponsor
Laura Case (Other)
Overall Status
Recruiting
CT.gov ID
NCT04206397
Collaborator
National Center for Complementary and Integrative Health (NCCIH) (NIH)
80
1
25.5
3.1

Study Details

Study Description

Brief Summary

This study compares how different types of touch found in massage therapies impact pain perception, and whether these effects differ in individuals with and without chronic pain. This study also examines psychological factors that may predict differences in touch perception in individuals with chronic pain. This research will improve our understanding of whether and how massage therapies can benefit pain and health, and whether this differs in people who suffer from chronic pain.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: affective touch
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Mechanisms of Affective Touch in Chronic Pain
Actual Study Start Date :
Sep 15, 2021
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Chronic pain levels using the Chronic Pain Grade Questionnaire [Day 1]

    The investigators will measure chronic pain levels using the Chronic Pain Grade Questionnaire. This measure will be included in a linear regression model to determine whether this measure significantly predicts differences in ratings of touch pleasantness.

  2. Trauma history using the Childhood Trauma Questionnaire [Day 1]

    The investigators will measure trauma history using the Childhood Trauma Questionnaire. This measure will be included in a linear regression model to determine whether this measure significantly predicts differences in ratings of touch pleasantness.

  3. Current depression using the Hospital Anxiety and Depression Scale without chronic pain [Day 1]

    The investigators will measure current depression using the Hospital Anxiety and Depression Scale. This measure will be included in a linear regression model to determine whether this measure significantly predicts differences in ratings of touch pleasantness.

  4. Ratings of affective touch [Day 1]

    Touch pleasant/unpleasantness ratings will be assessed in response to each sensory stimulus (brushing, tapping, and pressure) using a Visual Analog Scale with anchors of "no pleasantness" to "most pleasant imaginable." Affective touch perception is the difference in ratings between the affective and neutral touch conditions during the baseline testing session and will be compared between individuals with and without chronic pain.

  5. Ratings of Heat Pain Intensity [Day 1]

    Pain intensity will be measured during the baseline and post-tests in the affective-Conditioned Pain Modulation blocks. Pain intensity will be assessed with a Visual Analog Scale with anchors from "no pain " to "most intense pain imaginable." VAS pain ratings will be compared before the cold water bath.

  6. Ratings of Heat Pain Intensity [Day 2]

    Pain intensity will be measured during the baseline and post-tests in the affective-Conditioned Pain Modulation blocks. Pain intensity will be assessed with a Visual Analog Scale with anchors from "no pain " to "most intense pain imaginable." VAS pain ratings will be compared before and after blocks of affective touch stimuli .

  7. Ratings of Heat Pain Unpleasantness [Day 1]

    Pain unpleasantness will be measured during the baseline and post-tests in the affective-Conditioned Pain Modulation blocks. Pain intensity will be assessed with a Visual Analog Scale with anchors from "no unpleasantness" to "most unpleasant pain imaginable." VAS pain ratings will be compared before and after the cold water bath.

  8. Ratings of Heat Pain Unpleasantness [Day 2]

    Pain unpleasantness will be measured during the baseline and post-tests in the affective-Conditioned Pain Modulation blocks. Pain intensity will be assessed with a Visual Analog Scale with anchors from "no unpleasantness" to "most unpleasant pain imaginable." VAS pain ratings will be compared before and after blocks of affective touch stimuli.

Secondary Outcome Measures

  1. Breathing rate [Day 1 and 2]

    Respiration rate will be measured during the baseline and during the affective touch and pain trials.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. ages 18-65

  2. fluent in English

  3. physician diagnosis of Fibromyalgia but no other chronic pain conditions (patients) or no evidence of chronic pain (healthy volunteers)

Exclusion Criteria:
  1. Sensory, motor, or anatomic differences or injuries relevant to study procedures

  2. Known anomalies of the central nervous system (including stroke, dementia, aneurysm, or personal history of psychosis)

  3. Pregnancy

  4. Inability to rate pain or sensations

  5. Major medical conditions such as kidney, liver, cardiovascular (hypertension, preexisting cardiac arrhythmia), autonomic, pulmonary, or neurological problems (e.g., seizure disorder) or a chronic systemic disease (e.g., diabetes).

  6. History of blood clots or first-degree family members with clotting disorders

  7. Current use of opiate medication(s)

  8. Contraindications to MRI if participating in pilot MRI study

  9. Unable to identify a heat stimulus 50C or lower that generates a rating of a 7 on our VAS scale

  10. History of fainting or seizures

  11. History of frostbite

  12. Open cut or sore on hand to be immersed in cold water bath

  13. Fracture of limb to be immersed

  14. History of Reynaud's phenomenon (hands get white, then blue on exposure to cold, then red on warming)

Contacts and Locations

Locations

Site City State Country Postal Code
1 ACTRI La Jolla California United States 92093

Sponsors and Collaborators

  • Laura Case
  • National Center for Complementary and Integrative Health (NCCIH)

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Laura Case, Assistant Professor, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT04206397
Other Study ID Numbers:
  • 191669
  • 4R00AT009466-02
First Posted:
Dec 20, 2019
Last Update Posted:
Mar 9, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2022